Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311539879> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W4311539879 abstract "Abstract Background Specific humoral response against pre-fusion (pre-F) conformation of respiratory syncytial virus (RSV) F protein has been proposed to play a role against severe infection. We aimed to analyze the association between serum IgG titers against pre-F and post-fusion (post-F) conformations of RSV F protein and life-threatening RSV disease (LTD) in previously healthy infants. Methods Prospective cohort study including previously healthy infants < 12 months, hospitalized with a first RSV infection, in 2017-2019. Patients were defined to have LTD when required intensive care and ventilatory support. Pre-F exclusive and post-F-specific antibody responses were determined by post-F competition and non-competitive immunoassays, respectively, and neutralizing activity was measured by plaque reduction neutralization test. Viral load (VL) was assessed by qRT-PCR from nasopharyngeal aspirates collected on admission. Serum samples were collected within 72 h from admission and in convalescence (between 14 to 60 days). Results Seventy-five patients were included, median age 3 months, 60% (n=45) were males; 21 patients developed LTD. Importantly, acute and convalescent post-F and pre-F exclusive IgG titers did not associate with LTD (Fig 1). There was a positive correlation between neutralizing antibody titers and pre-F exclusive IgG titers (p=0.016). Post-F and pre-F exclusive IgG titers negatively correlated with age in acute phase (p< 0.0001 and p= 0.0009). In acute phase, post-F and pre-F exclusive IgG titers were higher in patients ≤ 2 months (Fig 2). Patients > 2 months increased post-F and pre-F exclusive IgG titers in convalescence. Additionally, post-F and pre-F exclusive titers did not correlate with VL, and VL was not related to LTD. Conclusion -Pre-F exclusive and post-F IgG titers did not associate with LTD, even though pre-F exclusive IgG correlated with neutralizing antibody titers. -Infants under two months of age developed a lower humoral response, likely due to an interference by maternal antibodies and/or immunological immaturity. -These findings highlight the importance of fully characterizing the immune response against RSV and its association with disease severity for the development of preventive strategies. Disclosures Barney S. Graham, MD, PhD, BSG: BSG is an inventor on patents for the stabilization of the RSV F protein (WO2014160463A1, Prefusion RSV F proteins and their use).|National Institutes of Health: Inventor on patents for RSV vaccines|National Institutes of Health: inventor on patents for measles and other paramyxovirus vaccines." @default.
- W4311539879 created "2022-12-27" @default.
- W4311539879 creator A5009078261 @default.
- W4311539879 creator A5016948733 @default.
- W4311539879 creator A5020755875 @default.
- W4311539879 creator A5021608465 @default.
- W4311539879 creator A5024637570 @default.
- W4311539879 creator A5032846589 @default.
- W4311539879 creator A5033763606 @default.
- W4311539879 creator A5038903505 @default.
- W4311539879 creator A5038985317 @default.
- W4311539879 creator A5041325206 @default.
- W4311539879 creator A5058592982 @default.
- W4311539879 creator A5061749851 @default.
- W4311539879 creator A5078120676 @default.
- W4311539879 date "2022-12-01" @default.
- W4311539879 modified "2023-09-26" @default.
- W4311539879 title "487. Analysis of the Association between Specific Antibody Response against Respiratory Syncytial Virus Fusion Protein Conformations and Life-Threatening Infection in Previously Healthy Infants" @default.
- W4311539879 doi "https://doi.org/10.1093/ofid/ofac492.545" @default.
- W4311539879 hasPublicationYear "2022" @default.
- W4311539879 type Work @default.
- W4311539879 citedByCount "0" @default.
- W4311539879 crossrefType "journal-article" @default.
- W4311539879 hasAuthorship W4311539879A5009078261 @default.
- W4311539879 hasAuthorship W4311539879A5016948733 @default.
- W4311539879 hasAuthorship W4311539879A5020755875 @default.
- W4311539879 hasAuthorship W4311539879A5021608465 @default.
- W4311539879 hasAuthorship W4311539879A5024637570 @default.
- W4311539879 hasAuthorship W4311539879A5032846589 @default.
- W4311539879 hasAuthorship W4311539879A5033763606 @default.
- W4311539879 hasAuthorship W4311539879A5038903505 @default.
- W4311539879 hasAuthorship W4311539879A5038985317 @default.
- W4311539879 hasAuthorship W4311539879A5041325206 @default.
- W4311539879 hasAuthorship W4311539879A5058592982 @default.
- W4311539879 hasAuthorship W4311539879A5061749851 @default.
- W4311539879 hasAuthorship W4311539879A5078120676 @default.
- W4311539879 hasBestOaLocation W43115398791 @default.
- W4311539879 hasConcept C126322002 @default.
- W4311539879 hasConcept C159047783 @default.
- W4311539879 hasConcept C159654299 @default.
- W4311539879 hasConcept C188816634 @default.
- W4311539879 hasConcept C203014093 @default.
- W4311539879 hasConcept C22889606 @default.
- W4311539879 hasConcept C2522874641 @default.
- W4311539879 hasConcept C2777945365 @default.
- W4311539879 hasConcept C2779261636 @default.
- W4311539879 hasConcept C32611913 @default.
- W4311539879 hasConcept C71924100 @default.
- W4311539879 hasConcept C72563966 @default.
- W4311539879 hasConcept C90924648 @default.
- W4311539879 hasConceptScore W4311539879C126322002 @default.
- W4311539879 hasConceptScore W4311539879C159047783 @default.
- W4311539879 hasConceptScore W4311539879C159654299 @default.
- W4311539879 hasConceptScore W4311539879C188816634 @default.
- W4311539879 hasConceptScore W4311539879C203014093 @default.
- W4311539879 hasConceptScore W4311539879C22889606 @default.
- W4311539879 hasConceptScore W4311539879C2522874641 @default.
- W4311539879 hasConceptScore W4311539879C2777945365 @default.
- W4311539879 hasConceptScore W4311539879C2779261636 @default.
- W4311539879 hasConceptScore W4311539879C32611913 @default.
- W4311539879 hasConceptScore W4311539879C71924100 @default.
- W4311539879 hasConceptScore W4311539879C72563966 @default.
- W4311539879 hasConceptScore W4311539879C90924648 @default.
- W4311539879 hasIssue "Supplement_2" @default.
- W4311539879 hasLocation W43115398791 @default.
- W4311539879 hasOpenAccess W4311539879 @default.
- W4311539879 hasPrimaryLocation W43115398791 @default.
- W4311539879 hasRelatedWork W1678510290 @default.
- W4311539879 hasRelatedWork W1972745941 @default.
- W4311539879 hasRelatedWork W1984647379 @default.
- W4311539879 hasRelatedWork W2022712590 @default.
- W4311539879 hasRelatedWork W2063036651 @default.
- W4311539879 hasRelatedWork W2090002905 @default.
- W4311539879 hasRelatedWork W2139983200 @default.
- W4311539879 hasRelatedWork W2364746690 @default.
- W4311539879 hasRelatedWork W4205873719 @default.
- W4311539879 hasRelatedWork W4377695660 @default.
- W4311539879 hasVolume "9" @default.
- W4311539879 isParatext "false" @default.
- W4311539879 isRetracted "false" @default.
- W4311539879 workType "article" @default.